Childhood Flu: Pediatricians Urge Vaccination
Following a severe flu season that claimed 190 children’s lives in the United States, the American Academy of Pediatrics has released updated recommendations to prevent complications during the 2026-2027 season.
The American Academy of Pediatrics (AAP) recommends annual influenza vaccination for all children ages six months and older as a key preventive measure for the 2026-2027 flu season.
The updated guidance follows a particularly severe influenza season in the United States, during which 190 pediatric deaths were reported. That number could rise as additional cases are confirmed.
According to the AAP, annual vaccination remains one of the most effective ways to reduce hospitalizations, serious complications, and influenza-related deaths among children.
Childhood Flu Vaccination Remains Essential
Recent figures highlight growing concerns among pediatric health experts. As of March 2026, only 48.9% of American children between six months and 17 years had received a flu vaccine.
Historically, approximately 85% of children who died from influenza were unvaccinated.
A study published in the medical journal Pediatrics found that flu vaccination can reduce the risk of influenza-related death among children and adolescents by 80%.
Additionally, the Centers for Disease Control and Prevention (CDC) estimated that flu vaccines prevented nearly 15,000 hospitalizations and 245 pediatric deaths during the 2024-2025 season.
When Should Children Receive Their Flu Vaccine?
The AAP recommends vaccinating children as soon as vaccines become available, ideally before the end of October, to provide protection ahead of peak influenza activity.
Pediatricians may administer any authorized influenza vaccine appropriate for a child’s age and medical condition.Some children may require two doses depending on their age and previous vaccination history.
The recommendations also encourage vaccination during pregnancy and breastfeeding, helping protect both mothers and their babies.
Early Treatment Can Prevent Serious Complications
Beyond vaccination, pediatricians emphasize recognizing flu symptoms and seeking medical attention when necessary.
Antiviral medications are recommended for hospitalized children, those experiencing severe or progressive illness, and patients at increased risk of influenza complications.
For otherwise healthy children, antiviral treatment may also be considered when started within 48 hours after symptoms begin.
One available treatment is baloxavir marboxil, marketed as Xofluza. A generic version could improve access for eligible pediatric patients during the upcoming season.
The AAP emphasizes that timely medical care, annual vaccination, and consultation with a pediatrician remain essential steps in protecting children from influenza.
